The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Interesting to see some individuals who have liked Vladislav's Linkedin post relating to the recent patent:
Lisa S. Hale - Funding Expert for Innovators and Tech Startups
A trusted leader for writing & reviewing grant submissions in Europe and the US. We have an 85% success rate in obtaining grant funds for our clients, achieved through our expertise in navigating and understanding the federal grant approval landscape.
Patrick Sturgeon - Managing Partner at Brookline Capital Markets
On their website you can see ongoing engagements/transactions with Biopharmaceutical companies:
https://brooklinecapmkts.com/completed-transactions/
Finally Magdalene Moran - CSO at Caraway Therapeutics, a subsidiary of Merck & Co
Is this Hemo’s clinical trials study?
https://clinicaltrials.gov/study/NCT05945849?locStr=United%20States&country=United%20States&cond=Acute%20Myeloid%20Leukemia&intr=CAR-T&page=2&rank=14
Full patent application link below for those interested:
https:// image-ppubs.uspto.gov / dirsearch-public / print / downloadPdf / 11104738
Very interesting read. Seems like all points are relevant in Hemo's current situation
^ oh dear.. :/
Ssccss, I am disappointed how it has came to this and yes bad decisions had been made on the board. However looking forward is all we can do now, CLNs removed and strongly believe this will rerate and improve long term. I am averaging just under 6p and so yes considerably down as a majority of investors here. What I was getting to my previous message is the character assasination of JHFH. It isn't his problem that some of us are underwater. It isn't his problem no-one else on the board called up to get involved with the placing. Can we just focus on the positives now CLNs have gone. This board used to be a good source of knowledge, but is it just filth now.
With all due respect Ssccss, thats not really JHFH's problem. He couldn't have said anything when he was inside. Did we expect him to spoon feed all PIs to ring up and get involved by offering a direct line or a templated email? What's done is done now. Everyone wanted CLNs gone and complained for months. Oh look.. their gone! Now everyone is looking for something/someone else to blame. Not one PI here was forced at gun point to press the buy button on Hemo. They did it with their own due diligence (you hope). We can only look forward now and focus on the science. GLA
It is expected that Admission will occur at 8.00 a.m. on or around 17 May 2021. If it is still Mint they should be done any day now
Don't forget the Global Life Sciences Conference today. Dr Vlad will be talking at 7am EST / 12pm GMT.
Register to view below:
https://pr.report/j9Lqa4Jk
It was only on the 25th where they stated 'The Company does not have any immediate plans for further drawdowns from the Convertible Notes Facility. ' - Id be surprised if another was coming so soon after.
https://total-market-solutions.com/2021/02/hemogenyx-pharmaceuticals-plc/
Sounds really exciting! Top secret. Still waiting to generate IP protection and patent rights but positive results against viral infection and cancer.
Yep same, got in at 6.90 :)
A rare business message:
#HEMO is in a great shape with a ton of money in their bank accounts.
#HEMO will deliver on their promise of getting their product candidates into the clinic - have no doubt about it. I am looking forward to see 2021 as the most productive year ever!
Licking their wounds.. but yes they will be back like anti-vaxxers to a pyramid scheme.
May have got this completely wrong but saw this sentence:
https://www.bbc.co.uk/news/health-51665497
"In the past two weeks, both Pfizer and BioNtech and Moderna have announced hugely successful trials of their Covid-19 vaccines. Others are in development, while a third major trial - from Belgian company Janssen - is under way in the UK."
Janssen being owned by Johnson & Johnson and the collab between JJ and Hemo. News must be imminent?